Results 241 to 250 of about 9,406,168 (354)

Combined Central and Peripheral Demyelinating Disease With Good Response to B-Cell Depleting Therapy. [PDF]

Cureus, 2021
Makkawi S, Yonbawi F, Qari Y, Aljinaid M.   +3 more
europepmc   +1 more source

Site-specific alteration of murine hepatitis virus type 4 peplomer glycoprotein E2 results in reduced neurovirulence [PDF]

, 1986
Buchmeier, M J, Dalziel, Robert, Lampert, P W, Talbot, Pierre J   +3 more
core  

Olfactory Pathology in Central Nervous System Demyelinating Diseases

, 2014
Gabriele C. DeLuca, Albert Joseph, Jithin George, Richard L. Yates, Marie Hamard, Monika Hofer, Margaret M. Esiri   +6 more
openalex   +2 more sources

Major linear antibody epitopes and capsid proteins differentially induce protective immunity against Theiler's virus-induced demyelinating disease [PDF]

, 1997
Hiroyuki Yahikozawa, Asuka Inoue, Chang‐Sung Koh, Yong Kyung Choe, B S Kim   +4 more
openalex   +1 more source

Charcot–Marie–Tooth disease misdiagnosed as chronic inflammatory demyelinating polyradiculoneuropathy: An international multicentric retrospective study

, 2021
Fabien Hauw, Guillaume Fargeot, David Adams, Shahram Attarian, Cécile Cauquil, Jean‐Baptiste Chanson, Alain Créange, Thierry Gendre, Kumaran Deiva, Émilien Delmont, Bruno Francou, Steeve Genestet, Thierry Küntzer, Philippe Latour, Gwendal Le Masson, Laurent Magy, Clotilde Nardin, François Ochsner, Guilhem Solé, Tanya Stojkovic, Thierry Maisonobe, Céline Tard, Peter Van Den Berghe, Andoni Echaniz‐Laguna   +23 more
openalex   +2 more sources

IFNγ Influences Type I Interferon Response and Susceptibility to Theiler's Virus-Induced Demyelinating Disease

Viral immunology, 2013
J. Bowen, J. Olson
semanticscholar   +1 more source

Nationwide Characterization of MFN2‐Related CMT in 176 Japanese Patients: Clinical and Genetic Insights

Annals of Clinical and Translational Neurology, Volume 13, Issue 1, Page 170-179, January 2026.
ABSTRACT Background Mitofusin 2 (MFN2) is a major causative gene for axonal Charcot – Marie – Tooth disease type 2A (CMT2A), with a wide phenotypic spectrum. Comprehensive large ‐ scale genotype – phenotype association studies are essential for understanding disease pathogenesis and improved clinical management.
Masahiro Ando, Yujiro Higuchi, Jun‐Hui Yuan, Akiko Yoshimura, Chikashi Yano, Takahiro Hobara, Fumikazu Kojima, Yu Hiramatsu, Satoshi Nozuma, Tomonori Nakamura, Yusuke Sakiyama, Jun Mitsui, Shoji Tsuji, Hiroshi Takashima   +13 more
wiley   +1 more source

Exploring the Role of Platelets in Virus-Induced Inflammatory Demyelinating Disease and Myocarditis. [PDF]

Int J Mol Sci
Ahmad I, Omura S, Sato F, Park AM, Khadka S, Gavins FNE, Tanaka H, Kimura MY, Tsunoda I.   +8 more
europepmc   +1 more source

Selective Depletion of Antigen-Specific Antibodies for the Treatment of Demyelinating Disease. [PDF]

Mol Ther, 2021
Sun W, Khare P, Wang X, Challa DK, Greenberg BM, Ober RJ, Ward ES.   +6 more
europepmc   +1 more source

Repurposing of Chemokine Antagonists for Combined Phase‐Resolved Spinal Cord Injury Treatment

Advanced Science, Volume 13, Issue 1, 5 January 2026.
Spinal cord injury (SCI) in mammals is accompanied by a massive cytokine storm in cerebrospinal fluid, mainly driven by CXCL1, IL‐6, and CCL2‐5. Sub‐acute phase is mostly associated with IL‐2, IL‐7, CCL22, and CX3CL1, whereas TNFα and IL17α permanently persists in CNS even weeks following SCI.
Alexey A. Belogurov Jr., Georgii B. Telegin, Aleksandr S. Chernov, Anna A. Kudriaeva, Alexey N. Minakov, Maksim V. Rodionov, Vitaly A. Kazakov, Viktor A. Palikov, Yuri M. Poluektov, Rustam H. Ziganshin, Daria A. Orlova, Alena S. Evpak, Daniil A. Barsuk, Fedor A. Mesheryakov, Aldo Spallone, Dmitry S. Asyutin, Igor N. Pronin, Nikolay A. Konovalov, Dmitri Yu Usachev, Alexander G. Gabibov, Alexander N. Konovalov   +20 more
wiley   +1 more source